09:40 AM EST - Aptilon Corp. : Aptilon Corp. announced that it has renewed contracts for 2009 with its existing roster of top 10 U.S. pharmaceutical clients for an approximate total of $6.3 million U.S. or $7.5 million, successfully moving several clients from first stage engagements to enterprise-level rollouts. In the first quarter, the company also signed contracts for five additional pharmaceutical brands for an approximate total of $1.2 million U.S. or $1.5 million. Aptilon Corp.
shares V.APZ are trading even at $0.11.
